This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 102/3/295    most recent CIRCRESAHA.107.157099v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buelens, K. Articles by Gils, A. Search for Related Content PubMed PubMed Citation Articles by Buelens, K. Articles by Gils, A. Related Collections Fibrinolysis Related Article

(Circulation Research. 2008;102:295.)
© 2008 American Heart Association, Inc.

Molecular Medicine

Biochemical Importance of Glycosylation in Thrombin Activatable Fibrinolysis Inhibitor

Karlien Buelens, Kerstin Hillmayer, Griet Compernolle, Paul J. Declerck, Ann Gils

From the Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium.

Correspondence to Ann Gils, Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Campus Gasthuisberg, O&N2, PB 824, Herestraat 49, B-3000 Leuven, Belgium. E-mail Ann.Gils{at}pharm.kuleuven.be

Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) exerts an antifibrinolytic effect by removing C-terminal lysines from partially degraded fibrin. These lysines are essential for a rapid conversion of plasminogen to plasmin by tissue type plasminogen activator. TAFI is heavily glycosylated at Asn²², Asn⁵¹, Asn⁶³, and Asn⁸⁶. Although the glycans occurring at the glycosylation sites have previously been identified, the biochemical role of these glycans is not known yet. Therefore, we have determined the biochemical importance of the glycosylation in TAFI. Four single, 6 double, 4 triple, and 1 quadruple mutant, in which asparagine was replaced by glutamine, were constructed and transfected into HEK293T cells. Based on the determination of antigen and activity levels on conditioned medium, 4 single and 1 triple mutant were purified and their biochemical properties were determined. The glycosylation knockout mutants did neither reveal an altered fragmentation pattern nor differences in TAFIa stability, but TAFI-N51Q, TAFI-N63Q, and TAFI-N22Q-N51Q-N63Q revealed a decreased TAFIa activity, an increased intrinsic catalytic activity of the zymogen, and a decreased antifibrinolytic potential compared with TAFI–wild-type, whereas TAFI-N22Q and TAFI-N86Q revealed an increased antifibrinolytic potential probably because of an increased catalytic efficiency toward the physiological substrate. From these data it can be concluded that mainly the glycosylation at Asn⁸⁶ contributes to the biochemical characteristics of TAFI. Furthermore we provide evidence that the activation peptide stays in close proximity to the TAFIa moiety after activation.

Key Words: TAFI • fibrinolysis • glycosylation

Related Article:

Glycosylation of Thrombin Activatable Fibrinolysis Inhibitor: Why Is it So Important?

Federico Biscetti
Circ. Res. 2008 102: 278-279. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				M. Delvaeye, M. Noris, A. De Vriese, C. T. Esmon, N. L. Esmon, G. Ferrell, J. Del-Favero, S. Plaisance, B. Claes, D. Lambrechts, et al. Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome N. Engl. J. Med., July 23, 2009; 361(4): 345 - 357. [Abstract] [Full Text] [PDF]

				F. Biscetti Glycosylation of Thrombin Activatable Fibrinolysis Inhibitor: Why Is it So Important? Circ. Res., February 15, 2008; 102(3): 278 - 279. [Full Text] [PDF]